You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site

Continue

Go back

Shingles and age

Age-related decline in immunity was shown to be the dominant driver of shingles 1

Age was shown to be the most important risk factor for the development of shingles. 1

2/3 of shingles cases occur in those over the age of 50. 1,3

Increasing age can cause a natural decline in immune system function. 2,3

Loss of VZV-specific cell-mediated immunity leads to viral reactivation, resulting in shingles. 2,3

References:

  1. Government of Canada. Canadian Immunization Guide: Part 4 – Active Vaccines. Available at https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-4-active-vaccines/page-8-herpes-zoster-(shingles)-vaccine.html. Accessed on November 30, 2017.
  2. Public Health Agency of Canada. An Advisory Committee Statement (ACS), National Advisory Committee on Immunization (NACI) – Updated Recommendations on the Use of Herpes Zoster Vaccines. Ottawa, Ontario: Public Health Agency of Canada; June 2018.
     https://www.canada.ca/en/services/health/publications/healthy-living/updated-recommendations-use-herpes-zoster-vaccines.html.
  3. SHINGRIX Product Monograph. GlaxoSmithKline Inc., October 13, 2017.